Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.

MLA

Friederike Lämmer, et al. “Correction: Cytosolic Hsp70 as a Biomarker to Predict Clinical Outcome in Patients with Glioblastoma.” PLoS ONE, vol. 16, no. 3, Jan. 2021, p. e0248612. EBSCOhost, https://doi.org/10.1371/journal.pone.0248612.

APA

Friederike Lämmer, Claire Delbridge, Silvia Würstle, Frauke Neff, Bernhard Meyer, Jürgen Schlegel, Kerstin A Kessel, Thomas E Schmid, Daniela Schilling, & Stephanie E Combs. (2021). Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma. PLoS ONE, 16(3), e0248612. https://doi.org/10.1371/journal.pone.0248612

Chicago

Friederike Lämmer, Claire Delbridge, Silvia Würstle, Frauke Neff, Bernhard Meyer, Jürgen Schlegel, Kerstin A Kessel, Thomas E Schmid, Daniela Schilling, and Stephanie E Combs. 2021. “Correction: Cytosolic Hsp70 as a Biomarker to Predict Clinical Outcome in Patients with Glioblastoma.” PLoS ONE 16 (3): e0248612. doi:10.1371/journal.pone.0248612.